FindTrial
Sign In

Retrospective analysis of the relationship between cyclosporine A trough concentration and GVHD incidence in children and prognosis after hematopoietic stem cell transplantation

Retrospective analysis of the relationship between cyclosporine A trough concentration and GVHD incidence in children and prognosis after hematopoietic stem cell transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034702
Enrollment
Unknown
Registered
2020-07-15
Start date
2020-07-31
Completion date
Unknown
Last updated
2020-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematopoietic stem cell transplantation

Interventions

cyclosporine concentration200:Nil

Sponsors

Hebei Yanda Lu Daopei Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: (1) Patients under 18 years of age who underwent transplantation in our hospital. (2) Patients should be treated with cyclosporine to prevent GVHD. (3) The detection method of cyclosporin uses the method of HPLC-MS

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
acute GVHD;chronic GVHD;cyclosporine A trough concentration;postoperative mortality;—

Countries

China

Contacts

Public ContactLei Wang Ziyi Yang

hebei yanda lu daopei hospital

yangziyi_55555@163.com+86 16601163767

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026